The quality of each tissue was evaluated using H&E-stained sections and PPIB and Polr2a/PPIB ISH stains
10.1016/S0140-6736(01)06526-6 [DOI] [PubMed] [Google Scholar] 5.Zoller H, Schaefer B, Vanclooster A, et al
One the other hand, SGLT2 inhibitors specifically alter renal hemodynamics and then reduce intraglomerular pressure [21, 24,25,26], and attenuate diabetes-associated hyperfiltration and tubular hypertrophy, as well as reduce the tubular toxicity of glucose to directly protect kidney [27]
Adjust the unit count for other concentrations using the table above
Lancet 366 , 649659 (2005)
[2] Clinical trials have shown that people taking Saxenda (subcutaneous liraglutide) for 56 weeks lost an average of 8% of their body weight